GFE’s PoET HCV receives CE-IVD mark

Frankfurt am Main, January 22, 2021. – GFE today announced the CE-IVD approval of its PoET® HCV blood screening NAT test. The PCR kit is used on GFE’s new, fully integrated NAT testing solution, the PoET® System. With this NAT test GFE continues its tradition as...